Health
Peer-reviewed study: Ivermectin cuts COVID infections, deaths by 75%
The evidence is so strong, the researchers believe, the anti-parasitic drug should become a standard therapy everywhere, hastening global recovery.
A new, peer-reviewed study finds that one of the cheap, widely available drugs that has been dismissed by the left, establishment media and many in the health establishment as a treatment for COVID-19 reduces infections, hospitalizations and deaths by about 75%.
Ivermectin, in more than 30 trials around the world, causes “repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease,” according to the study, which will be published in the U.S. journal Frontiers of Pharmacology, DailyMail.com reported.
The evidence is so strong, the researchers believe, the anti-parasitic drug should become a standard therapy everywhere, hastening global recovery.
“The data is overwhelming – we are in a pandemic, and this is an incredibly effective way to combat it. If we use ivermectin widely, our societies can open up,” said study co-author Professor Paul Marik, director of emergency and pulmonary care at Eastern Virginia Medical School.